|Events|March 16, 2023
Decentralized Clinical Trials (4/18 - 4/20/23)
Advertisement
Decentralized Clinical Trials
April 18-20, 2023
Marriott Cambridge Hotel, Boston
April 18-20, 2023
Marriott Cambridge Hotel, Boston
Register your free pass* for the annual Decentralized Clinical Trials taking place April 18-20 in Boston here .
Put yourself at the forefront of clinical discovery, cutting edge strategies and ground-breaking technology at Decentralized Clinical Trials Hybrid Event dedicated to unravelling the hypes so you can leverage the benefits to achieve better patient outcomes.
Join a top speaker line-up to learn and learn from Craig Lipset and many others about the latest developments across a number of topic areas including:
Put yourself at the forefront of clinical discovery, cutting edge strategies and ground-breaking technology at Decentralized Clinical Trials Hybrid Event dedicated to unravelling the hypes so you can leverage the benefits to achieve better patient outcomes.
Join a top speaker line-up to learn and learn from Craig Lipset and many others about the latest developments across a number of topic areas including:
- Patient Centricity, Diversity and Inclusion
- Partnerships, Consortiums and Site Perspectives
- Regulatory Updates and Technology Digitalization
(*T&Cs apply. See the Decentralized Clinical Trials website for details.)
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- SCRS Global Site Solutions Summit (9/27 - 9/29/24)
March 18th 2024
- Life Sciences Accounting & Reporting Congress, 3/26-3/28/24
January 24th 2024
- Rare Disease Summit, 3/19-3/21/24
January 24th 2024
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
2
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
3
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
4
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
5